Bone marrow transplantation for the treatment of acute nonlymphoblastic leukemia in children aged less than 2 years.
Eleven children with acute nonlymphoblastic leukemia in first remission who were less than 2 years of age at diagnosis were treated with 120 mg/kg of cyclophosphamide, 12-Gy fractionated total-body irradiation, and marrow transplantation. Seven patients remain in complete remission from 3.5 to 13.8 years posttransplant, four for more than 6.75 years. The immediate posttransplant course was relatively uncomplicated in surviving patients. No child developed severe graft-v-host disease. The major long-term side effect has been a slowing in growth. Although the prognosis for such children with conventional chemotherapy remains poor, intensive cytotoxic therapy and marrow transplantation offers an alternative therapy with a chance for cure.
Johnson
F L
FL
Children's Hospital and Medical Center, Seattle.
Sanders
J E
JE
Ruggiero
M
M
Chard
R L
RL
Thomas
E D
ED
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002386:Cataract / Q000209:etiology; D003131:Combined Modality Therapy; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000188:drug therapy / Q000628:therapy*; D011183:Postoperative Complications; D011300:Preoperative Care